Search

everythinglearnresearchcommunity

for

Search:↓

People with early onset baldness (AGA) have higher blood sugar levels and lower sex hormone-binding globulin (SHBG) levels, suggesting SHBG could predict high blood sugar in these individuals.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

TRH stimulates human hair growth and extends the hair growth phase.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Cattle skin has leptin which might control skin and hair growth.

No link found between specific genes and female pattern hair loss.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Caffeine may help reduce stress-induced hair loss.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A woman's premature gray hair turned mostly black again after using Greyverse solution and hair supplements for 5 months.